Validated UPLC/QTOF-MS Method for Quantitative Determination of Salannin in Wistar Rat Plasma: In Vitro Assay, Ex Vivo Stability Effects and Pharmacokinetic Investigation

2012 ◽  
Vol 16 (1) ◽  
pp. 173-178
Author(s):  
Md Tanwir Athar ◽  
S. Mohamed Musthaba ◽  
Javed Ali ◽  
Sanjula Baboota ◽  
Sayeed Ahmad
2020 ◽  
Vol 386 ◽  
pp. 114831 ◽  
Author(s):  
Darja Gramec Skledar ◽  
Václav Tvrdý ◽  
Maša Kenda ◽  
Anamarija Zega ◽  
Milan Pour ◽  
...  

2006 ◽  
Vol 13 (1) ◽  
pp. 19-25 ◽  
Author(s):  
Erik L. Munson ◽  
Dean T. Nardelli ◽  
K. H. Kevin Luk ◽  
Monica C. Remington ◽  
Steven M. Callister ◽  
...  

ABSTRACT Determination of the immunological mediators responsible for promoting the production of borreliacidal antibody may facilitate the development of an improved borreliosis vaccine for human and veterinary use. Previously, we developed an in vitro assay to determine if borreliacidal antibody production could be augmented by treatment with different cytokines. In this study, in vitro treatment of lymph node cells producing borreliacidal antibody with recombinant interleukin-6 (rIL-6) resulted in a fourfold enhancement of anti-OspA borreliacidal antibody. Moreover, rIL-6 enhanced Western immunoblot titers and increased the number of B lymphocytes. In contrast, treatment of anti-OspA borreliacidal antibody-producing cells with anti-IL-6 resulted in a fourfold reduction in borreliacidal activity. Treatment with anti-IL-6 also inhibited enhanced borreliacidal antibody production induced by anti-gamma interferon. These data suggest that IL-6 plays a significant role in the production of anti-OspA borreliacidal antibodies.


2004 ◽  
Vol 325 (1) ◽  
pp. 85-91 ◽  
Author(s):  
Abhai K Tripathi ◽  
Shabana I Khan ◽  
Larry A Walker ◽  
Babu L Tekwani

2006 ◽  
Vol 20 (5) ◽  
pp. 434-438 ◽  
Author(s):  
Zohra Bendouah ◽  
Jean Barbeau ◽  
Walid Abou Hamad ◽  
Martin Desrosiers

1971 ◽  
Vol 49 (3) ◽  
pp. 487-492 ◽  
Author(s):  
JANICE M. ENSOR ◽  
PAT KENDALL-TAYLOR ◽  
D. S. MUNRO ◽  
B. R. SMITH

SUMMARY The McKenzie (1958) assay method and an in-vitro assay method (Brown & Munro, 1967) for the determination of long-acting thyroid stimulator have been compared. Differences in the results were not great: the in-vitro method is simpler to perform and more precise. The sensitivity of the two methods is similar. The in-vitro method, when used with antiserum to thyroid-stimulating hormone in the medium, provided a satisfactory and simple means for the assay of long-acting thyroid stimulator in the serum of thyrotoxic patients.


2000 ◽  
Vol 79 (1) ◽  
pp. 87-97 ◽  
Author(s):  
Magnus Doverskog ◽  
Ulla Jacobsson ◽  
Bodgan E Chapman ◽  
Philip W Kuchel ◽  
Lena Häggström

Sign in / Sign up

Export Citation Format

Share Document